Dianthus Therapeutics | MGTA - EPS Earnings Per Share



Dianthus Therapeutics reported $-0.88 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025.


Eps Change Date
Adcock Ingram Holdings ZAR 2.59 0.17 Dec/2024
Alaunos Therapeutics USD -0.46 0.24 Dec/2024
Avita Medical USD -0.21 0.05 Dec/2024
Celltrion KRW 810.39 301.74 Jun/2025
Cspc Pharmaceutical CNY 0.13 0.08 Mar/2025
Dianthus Therapeutics USD -0.88 0.07 Jun/2025
Divis Laboratories Ltd 20.49 4.26 Jun/2025
IQVIA Holdings USD 2.81 0.11 Jun/2025
Kangmei Pharma CNY 0 0 Jun/2025
Knight Therapeutics CAD 0 0.02 Sep/2024
Laboratorios Farma 0.42 1.39 Jun/2025
Malin Corporation 0 0 Dec/2024
Medical Developments International AUD 0 0.34 Dec/2024
Moderna USD -2.13 0.39 Jun/2025
Neuren Pharmaceuticals AUD 1.02 0.96 Dec/2024
Organigram Holdings CAD -0.05 0.16 Jun/2025
Organon & Co USD 1 0.02 Jun/2025
Pharma Mar EUR 1.32 1.55 Jun/2025
Qiagen NV USD 0.6 0.12 Jun/2025
Revvity USD 1.18 0.17 Jun/2025
Sartorius EUR 0.47 0.75 Jun/2025
Sino Biopharmaceutical CNY 0.19 0.16 Jun/2025
Tectonic Therapeutic USD -1.07 0.23 Jun/2025
Tilray USD -1.78 0.54 Jun/2025
Viatris USD 0.62 0.12 Jun/2025
Xeris Pharmaceuticals USD -0.01 0.02 Jun/2025
Zhangzhou Pientzehuang Pharmaceutical 0.73 0.93 Jun/2025